MUTAGENESIS OF THE PUTATIVE ALPHA-HELICAL DOMAIN OF THE VPR PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - EFFECT ON STABILITY AND VIRION INCORPORATION

被引:71
|
作者
MAHALINGAM, S
KHAN, SA
MURALI, R
JABBAR, MA
MONKEN, CE
COLLMAN, RG
SRINIVASAN, A
机构
[1] THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19107
[2] INFIN BIOTECH RES & RESOURCE,UPLAND,PA 19015
[3] UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104
[4] CLEVELAND CLIN FDN,DEPT MOLEC BIOL,CLEVELAND,OH 44195
[5] UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104
关键词
SECONDARY STRUCTURE; IMMUNOPRECIPITATION;
D O I
10.1073/pnas.92.9.3794
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
vpr is one of the auxiliary genes of human immunodeficiency virus type 1 (HIV-1) and is conserved in the related HIV-2/simian immunodeficiency virus lentiviruses, The unique feature of Vpr is that it is the only nonstructural protein incorporated into the virus particle, Secondary structural analysis predicted an amphipathic alpha-helical domain in the amino terminus of Vpr (residues 17-34) which contains five acidic and four leucine residues. To evaluate the role of specific residues of the helical domain for virion incorporation, mutagenesis of this domain was carried out. Substitution of proline for any of the individual acidic residues (Asp-17 and Glu-21, -24, -25, and -29) eliminated the virion incorporation of Vpr and also altered the stability of Vpr in cells. Conservative replacement of glutamic residues of the helical domain with aspartic residues resulted in Vpr characteristic of wild type both in stability and virion incorporation, as did substitution of glutamine for the acidic residues, In contrast, replacement of leucine residues of the helical domain (residues 20, 22, 23, and 26) by alanine eliminated virion incorporation function of Vpr. These data indicate that acidic and hydrophobic residues and the helical structure in this region are critical for the stability of Vpr and its efficient incorporation into virus-like particles.
引用
收藏
页码:3794 / 3798
页数:5
相关论文
共 50 条
  • [31] MUTAGENESIS OF PROTEASE CLEAVAGE SITES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG POLYPROTEIN
    TRITCH, RJ
    CHENG, YSE
    YIN, FH
    ERICKSONVIITANEN, S
    JOURNAL OF VIROLOGY, 1991, 65 (02) : 922 - 930
  • [32] ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN
    ALBINI, A
    BARILLARI, G
    BENELLI, R
    GALLO, RC
    ENSOLI, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) : 4838 - 4842
  • [33] FUNCTIONAL DOMAINS OF THE CAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    DORFMAN, T
    BUKOVSKY, A
    OHAGEN, A
    HOGLUND, S
    GOTTLINGER, HG
    JOURNAL OF VIROLOGY, 1994, 68 (12) : 8180 - 8187
  • [34] TRANSCELLULAR TRANSACTIVATION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN
    HELLAND, DE
    WELLES, JL
    CAPUTO, A
    HASELTINE, WA
    JOURNAL OF VIROLOGY, 1991, 65 (08) : 4547 - 4549
  • [35] Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein
    Karczewski, MK
    Strebel, K
    JOURNAL OF VIROLOGY, 1996, 70 (01) : 494 - 507
  • [36] MUTATIONAL DEFINITION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV ACTIVATION DOMAIN
    MALIM, MH
    MCCARN, DF
    TILEY, LS
    CULLEN, BR
    JOURNAL OF VIROLOGY, 1991, 65 (08) : 4248 - 4254
  • [37] EFFECT OF NEF ALLELES ON REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ZAZOPOULOS, E
    HASELTINE, WA
    VIROLOGY, 1993, 194 (01) : 20 - 27
  • [38] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366
  • [39] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [40] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480